Background: Dysphagia due to bulbar involvement is a major symptom of patients with spinal and bulbar muscular atrophy (SBMA). The aim of this pilot study was to test the efficacy and safety of the head lift exercise for swallowing dysfunction in SBMA. Methods: We enrolled 6 subjects with genetically confirmed SBMA and instructed them to perform the head lift exercise for 6 weeks. The efficacy outcome measures were the changes from baseline in tongue pressure, the scores of swallowing functional questionnaires, and the motor functional scales and parameters of videofluorography (VF). Results: All subjects completed the study and no major adverse effects were recorded. Tongue pressure significantly increased by 19.2 ± 0.15% (p < 0.05) after the 6-week head lift exercise. The scores for oral dysphagia also improved, although there was no significant change in VF parameters or other variables examined pre- and post-exercise. Conclusion: Our findings suggested that the head lift exercise may improve swallowing dysfunction, particularly tongue pressure, in SBMA.

1.
Kennedy WR, Alter M, Sung JH: Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968;18:671-680.
2.
Sobue G, Hashizume Y, Mukai E, et al: X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989;112:209-232.
3.
Sperfeld AD, Karitzky J, Brummer D, et al: X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 2002;59:1921-1926.
4.
Fischbeck KH: Kennedy disease. J Inherit Metab Dis 1997;20:152-158.
5.
Katsuno M, Tanaka F, Adachi H, et al: Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog Neurobiol 2012;99:246-256.
6.
Hashizume A, Katsuno M, Banno H, et al: Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 2012;135:2838-2848.
7.
Mano T, Katsuno M, Banno H, et al: Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Neurology 2014;82:255-262.
8.
Atsuta N, Watanabe H, Ito M, et al: Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006;129:1446-1455.
9.
Finsterer J: Bulbar and spinal muscular atrophy (Kennedy's disease): a review. Eur J Neurol 2009;16:556-561.
10.
Logemann JA, Rademaker A, Pauloski BR, et al: A randomized study comparing the Shaker exercise with traditional therapy: a preliminary study. Dysphagia 2009;24:403-411.
11.
Antunes EB, Lunet N: Effects of the head lift exercise on the swallow function: a systematic review. Gerodontology 2012;29:247-257.
12.
Shaker R, Easterling C, Kern M, et al: Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology 2002;122:1314-1321.
13.
Yoshida M, Groher ME, Crary MA, et al: Comparison of surface electromyographic (sEMG) activity of submental muscles between the head lift and tongue press exercises as a therapeutic exercise for pharyngeal dysphagia. Gerodontology 2007;24:111-116.
14.
Doyu M, Sobue G, Mukai E, et al: Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 1992;32:707-710.
15.
McHorney CA, Robbins J, Lomax K, et al: The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia 2002;17:97-114.
16.
Wada M, Hoshino Y, Okudaire N, et al: Assessment of quality of life for people with dysphagia: use of the SF-36 and trial use of the SWAL-QOL and SWAL-CARE outcomes tool in Japan. Jpn J Dysphagia Rehabil 2003;7:109-116.
17.
Yamamoto T, Ikeda K, Usui H, et al: Validation of the Japanese translation of the swallowing disturbance questionnaire in Parkinson's disease patients. Qual Life Res 2012;21:1299-1303.
18.
Eisenhuber E, Schima W, Schober E, et al: Videofluoroscopic assessment of patients with dysphagia: pharyngeal retention is a predictive factor for aspiration. AJR Am J Roentgenol 2002;178:393-398.
19.
Pikus L, Levine MS, Yang YX, et al: Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol 2003;180:1613-1616.
20.
Daggett A, Logemann J, Rademaker A, Pauloski B: Laryngeal penetration during deglutition in normal subjects of various ages. Dysphagia 2006;21:270-274.
21.
Katsuno M, Banno H, Suzuki K, et al: Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010;9:875-884.
22.
Logemann JA, Kahrilas PJ, Begelman J, et al: Interactive computer program for biomechanical analysis of videoradiographic studies of swallowing. AJR Am J Roentgenol 1989;153:277-280.
23.
Logemann JA: The potential future of dysphagia: population-specific diagnosis and treatment. Folia Phoniatr Logop 2000;52:136-141.
24.
Banno H, Adachi H, Katsuno M, et al: Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol 2006;59:520-526.
25.
Kuhlemeier KV, Yates P, Palmer JB: Intra- and interrater variation in the evaluation of videofluorographic swallowing studies. Dysphagia 1998;13:142-147.
26.
Kawai S, Tsukuda M, Mochimatsu I, et al: A study of the early stage of dysphagia in amyotrophic lateral sclerosis. Dysphagia 2003;18:1-8.
27.
Rogers B, Stratton P, Msall M, et al: Long-term morbidity and management strategies of tracheal aspiration in adults with severe developmental disabilities. Am J Ment Retard 1994;98:490-498.
28.
Tanaka S, Banno H, Katsuno M, et al: Distinct acoustic features in spinal and bulbar muscular atrophy patients with laryngospasm. J Neurol Sci 2014;337:193-200.
29.
Besinger UA, Toyka KV, Hömberg M, et al: Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 1983;33:1316-1321.
30.
Brinkmann JR, Andres P, Mendoza M, Sanjak M: Guidelines for the use and performance of quantitative outcome measures in ALS clinical trials. J Neurol Sci 1997;147:97-111.
31.
Shaker R, Kern M, Bardan E, et al: Augmentation of deglutitive upper esophageal sphincter opening in the elderly by exercise. Am J Physiol 1997;272:1518-1522.
32.
Woo HS, Won SY, Chang KY: Comparison of muscle activity between two adult groups according to the number of Shaker exercise. J Oral Rehabil 2014;41:409-415.
33.
Shaker R, Easterling C, Kern M, et al: Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology 2002;122:1314-1321.
34.
Easterling C, Grande B, Kern M, et al: Attaining and maintaining isometric and isokinetic goals of the Shaker exercise. Dysphagia 2005;20:133-138.
35.
Fratta P, Nirmalananthan N, Masset L, et al: Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology 2014;82:2077-2084.
36.
Goyal RK: Disorders of the cricopharyngeus muscle. Otolaryngol Clin North Am 1984;17:115-130.
37.
Bosma JF, Brodie DR: Disabilities of the pharynx in amyotrophic lateral sclerosis as demonstrated by cineradiography. Radiology 1969;92:97-103.
38.
Hiiemae KM, Palmer JB: Tongue movements in feeding and speech. Crit Rev Oral Biol Med 2003;14:413-429.
39.
Tong B, Fang R, Smith BL: Study of the head and neck position in microlaryngoscopy using magnetic resonance imaging. Eur Arch Otorhinolaryngol 2013;270:243-247.
40.
Preisler N, Andersen G, Thøgersen F, et al: Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). Neurology 2009;72:317-323.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.